Safety of radiosurgery applied to conditions with abnormal tumor suppressor genes

Neurosurgery

Volumn 60, Issue 5, 2007, Pages 860-863

  Rowe, Jeremy ^a   Grainger, Alison ^a   Walton, Lee ^a   Radatz, Matthias ^a   Kemeny, Andras ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Neurofibromatosis; Radiation induced malignancy; Von Hippel Lindau disease

Indexed keywords

ADULT; ARTICLE; BRAIN TUMOR; COHORT ANALYSIS; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAFETY; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENES, TUMOR SUPPRESSOR; HIPPEL-LINDAU DISEASE; HUMANS; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 2; RADIOSURGERY; RETROSPECTIVE STUDIES;

EID: 34247595911     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000255426.08926.95     Document Type: Article

References (21)

1. Bari ME, Forster DM, Kemeny AA, Walton L, Hardy D, Anderson JR: Malignancy in a vestibular schwannoma. Report of a case with central neurofibromatosis, treated by stereotactic radiosurgery and surgical excision, with a review of the literature. Br J Neurosurg 16:284-289, 2002.
2. Baser ME, Evans DG, Jackler RK, Sujansky E, Rubenstein A: Neurofibromatosis 2, radiosurgery and malignant nervous system tumours. Br J Cancer 82:998, 2000.
3. Chang SD, Meisel JA, Hancock SL, Martin DP, McManus M, Adler JR Jr: Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. Neurosurgery 43:28-35, 1998.
4. Evans DG, Baser ME, O'Reilly B, Rowe J, Gleeson M, Saeed S, King A, Huson SM, Kerr R, Thomas N, Irving R, MacFarlane R, Ferner R, McLeod R, Moffat D, Ramsden R: Management of the patient and family with neurofibromatosis 2: A consensus conference statement. Br J Neurosurg 19:5-12, 2005.
5. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R: A clinical study of type 2 neurofibromatosis. Q J Med 84:603-618, 1992.
6. Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R: Incidence of vestibular schwannoma and neurofibromatosis 2 in the north west of England over a 10-year period: Higher incidence than previously thought. Otol Neurotol 26:93-97, 2005.
7. Kaelin WG Jr: The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem Biophys Res Commun 338:627-638, 2005.
8. Kida Y, Kobayashi T, Tanaka T, Mori Y: Radiosurgery for bilateral neurinomas associated with neurofibromatosis type 2. Surg Neurol 53:383-390, 2000.
9. Knudson AG Jr: Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820-823, 1971.
10. Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris R, Sampson J, Williams A, Ferguson-Smith MA, Morton N: Von Hippel-Lindau disease: A genetic study. J Med Genet 28:443-447, 1991.
11. Noren G: Long-term complications following gamma knife radiosurgery of vestibular schwannomas. Stereotact Funct Neurosurg 70 [Suppl 1]:65-73, 1998.
12. Page KA, Wayson K, Steinberg GK, Adler JR Jr: Stereotaxic radiosurgical ablation: An alternative treatment for recurrent and multifocal hemangioblastomas. A report of four cases. Surg Neurol 40:424-428, 1993.
13. Rajaraman C, Rowe JG, Walton L, Malik I, Radatz M, Kemeny AA: Treatment options for von Hippel-Lindau's haemangioblastomatosis: The role of gamma knife stereotactic radiosurgery. Br J Neurosurg 18:338-342, 2004.
14. Ramesh V: Merlin and the ERM proteins in Schwann cells, neurons and growth cones. Nat Rev Neurosci 5:462-470, 2004.
15. Roche PH, Regis J, Pellet W, Thomassin JM, Gregoire R, Dufour H, Peragut JC: Neurofibromatosis type 2. Preliminary results of gamma knife radiosurgery of vestibular schwannomas [in French]. Neurochirugie 46:339-354, 2000.
16. Rowe J, Grainger A, Walton L, Silcocks P, Radatz M, Kemeny A: Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery 60:60-66, 2007.
17. Rowe JG, Radatz MW, Walton L, Kemeny AA: Changing utilization of stereo-tactic radiosurgery in the UK: The Sheffield experience. Br J Neurosurg 16:477-482, 2002.
18. Rowe JG, Radatz MW, Walton L, Soanes T, Rodgers J, Kemeny AA: Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis. J Neurol Neurosurg Psychiatry 74:1288-1293, 2003.
19. Samii M, Matthies C, Tatagiba M: Management of vestibular schwannomas (acoustic neuromas): Auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2. Neurosurgery 40:696-706, 1997.
20. Subach BR, Kondziolka D, Lunsford LD, Bissonette DJ, Flickinger JC, Maitz AH: Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis Type 2. J Neurosurg 90:815-822, 1999.
21. Thomsen J, Mirz F, Wetke R, Astrup J, Bojsen-Moller M, Nielsen E: Intracranial sarcoma in a patient with neurofibromatosis type 2 treated with gamma knife radiosurgery for vestibular schwannoma. Am J Otol 21:364-370, 2000.